Integrative Potential of Majoon Suranjan in the Management of Varicose Veins: A Review of Unani Humoral Theory and Contemporary Molecular Mechanisms
Abstract
Background: Chronic Venous Disease (CVD), traditionally known as Dawali, involves complex vascular remodelling. While the Unani System of Medicine (USM) has long utilised Majoon Suranjan (MS) for its resolvent (Muhallil) properties, its molecular interactions with modern vascular science remain underexplored.
Objectives: This review aims to synthesise classical Unani humoral theories of venous stasis with modern molecular mechanisms, with a specific focus on the regulation of Matrix Metalloproteinases (MMPs) by the bioactive constituents of Majoon Suranjan.
Methods: A comprehensive analysis of classical Unani texts (e.g., Al-Qanun Fi’l Tibb) was integrated with contemporary pharmacological data and bibliographic trends (2014–2024) regarding Majoon Suranjan (MS) and chief ingredient Colchicum luteum and its primary alkaloid, colchicine.
Results: The study identifies a significant conceptual convergence between the Unani "atrabilious matter" (Sauda) and modern hemorheological stasis. Mechanistically, the Muhallil action of Majoon Suranjan aligns with the inhibition of MMP-9 and the NLRP3 inflammasome, which prevents the degradation of the extracellular matrix (ECM) and stabilises the venous wall. Furthermore, the polyherbal synergism of ingredients like Zingiber officinale and Piper longum enhances microcirculation and mitigates tropolone alkaloid toxicity.
Conclusion: Majoon Suranjan serves as a scientifically plausible integrative therapy for varicose veins. Future clinical research utilising Doppler-derived hemodynamic and proteomic profiling is recommended to establish its role in standard vascular care.
Keywords: Majoon Suranjan, Varicose Veins, Dawali, Colchicum luteum, Matrix Metalloproteinases (MMP-9), Unani Medicine, Colchicine.
Keywords:
Majoon Suranjan, Varicose Veins, Dawali, Colchicum luteum, Unani Medicine, ColchicineDOI
https://doi.org/10.22270/jddt.v16i5.7743References
1. Central Council for Research in Unani Medicine. Fundamentals of Unani Medicine Internet. New Delhi: Ministry of AYUSH, Government of India; 2020 cited 2026 Apr 28. Available from: https://ccrum.res.in/writereaddata/UploadFile/Fundamentals%20of%20Unani%20Medicine%20637339132286554782.pdf
2. Sahiba, et al. Indian Journal of Unani Medicine. 2025 Jan-Jun;18(1):15-19. Available from: http://journal.nesa-india.org/archieve-files/IJUM/2025/Paper2_IJUM_Vol18_Issue_1_2025.pdf https://doi.org/10.53390/IJUM.2025.18102
3. Alam MA, Zarnigar, Alam MT. Dawali (Varicose Veins): Description in the Unani System of Medicine. World J Adv Healthcare Res. 2020;4(2):273-280.
4. Ibn Sina. Al-Qanun Fi’l Tibb: Book II. English Translation. New Delhi: Deptt. of Jamia Hamdard; 1998. p. 276-277.
5. Dar MY, Sajid M, Gani R, Shah AJ, Meena R, Akbar S, et al. Pharmacognostic and Phytochemical Characteristics of the Colchicum luteum Baker (Suranjan) growing wild in Kashmir Valley, India. Res J Pharm Technol. 2023;16(12):5728-1. https://doi.org/10.52711/0974-360X.2023.00926
6. Kalam MA, Anjum F. Suranjan (Colchicum autumnale L. and merendra persica): Great resolvent herbs of Unani system of medicine - a review. Int J Unani Integr Med. 2019;3(4):349-354. https://doi.org/10.33545/2616454X.2020.v4.i1a.115
7. Khan AA, Bashir F, Akhtar J, Anjum N, Alam S, Naushin S. Majoon Suranjan: A Potent Unani formulation for Arthritis. J Drug Delivery Ther Internet. 2018 Nov 15 cited 2026 Mar 12;8(6):351-5. Available from: https://jddtonline.info/index.php/jddt/article/view/2149 https://doi.org/10.22270/jddt.v8i6.2149
8. Siddique H, Singh D, Khan M. Protective effects of a polyherbal medicine, Majoon Suranjan against bisphenol-A induced genetic, oxidative and tissue damages. Drug Chem Toxicol. 2023;46(4):689-700. https://doi.org/10.1080/01480545.2022.2124519 PMid:36120934
9. Khan AA, Bashir F, Akhtar J, Anjum N, Alam S, Naushin S, Majoon Suranjan: A Potent Unani formulation for Arthritis, Journal of Drug Delivery and Therapeutics. 2018; 8(6):351-355 https://doi.org/10.22270/jddt.v8i6.2149
10. Rather RA, et al. The Assessment of Morphological Diversity of Colchicum luteum L., an Economically Important Threatened Medicinal Plant of Kashmir Himalaya. Sustainability. 2022;14(3):1327. https://doi.org/10.3390/su14031327
11. Singh S, Nair V, Gupta YK. Antiarthritic activity of Majoon Suranjan (a polyherbal Unani formulation) in rats. Indian J Med Res. 2011;134(3):384-388.
12. American Venous Forum. What is Chronic Venous Disease? Internet. place unknown: American Venous Forum; date unknown cited 2026 Apr 28. Available from: https://www.venousforum.org/patients/what-is-vein-disease/what-is-chronic-venous-disease/
13. Kabiruddin HM. Makhazan al-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p. 270.
14. Singh S, et al. Anti-inflammatory and antioxidant evaluation of Himalayan herb Colchicum luteum. Am J Transl Res. 2025;17(2):1018-1028.
15. Khan Azam M. Muhit-i-Azam. Vol 3. New Delhi: Central Council for Research in Unani Medicine; 2014. p. 194-197.
16. Pullaiah T. Encyclopedia of World Medicinal Plants. Vol 2. New Delhi: Regency Publications; 2006. p. 615-616.
17. Ibn Baitar. Al Jami Li Mufradat al-Advia wa al-Aghzia. Vol 3. New Delhi: Central Council for Research in Unani Medicine; 1999. p. 96-98.
18. Suryono, et al. Colchicine as potential inhibitor targeting MMP-9, NOX2 and TGF-beta1 in myocardial infarction: a combination of docking and molecular dynamic simulation study. J Biomol Struct Dyn. 2023;41(22):12745-12754. PMid:36636837 https://doi.org/10.1080/07391102.2023.2166590
19. Masihi AFIAQ. Kitabul Umdah fil Jarahat. Vol. I & II. Urdu Translation by Literary Research unit Lucknow. New Delhi: CCRUM Ministry of Health & Family Welfare; 1986. p. 84-85, 172.
20. Ibn Sina. Alqanoon Fil Tib. Vol III. Urdu Translation by Kantoori GH. New Delhi: Idara Kitabul Shifa; 2007. p. 371-373.
21. Kausar C. Moajazul Qanoon. New Delhi: Quaumi Council Barae Farogh Urdu Zaban. p. 402.
22. Khan MA. Alakseer. Vol II. Urdu Translation by Kabiruddin M. New Delhi: Ejaz Publishing House; 2003. p. 1428-1429.
23. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248-1252. https://doi.org/10.1016/j.jvs.2004.09.027 PMid:15622385
24. Zhou H, Khan D, Hussain SM, et al. Colchicine prevents oxidative stress-induced endothelial cell senescence via blocking NF-kappa B and MAPKs: implications in vascular diseases. Front Cardiovasc Med. 2023;10:1283624. https://doi.org/10.1101/2023.08.04.552075
25. Anonymous. National Formulary of India. New Delhi: Central Council for Research in Unani Medicine, Govt of India; 2006. Part 1: p. 144.
26. Saleem SS, Bibi R, Gillani SMUM, Alqahtani N, Syed W, Ibrar M, et al. Synergistic effect of Majoon-e-Suranjaan and isometric exercises in improving rheumatoid arthritis. Am J Transl Res. 2025 Feb 15;17(2):1018-1028. https://doi.org/10.62347/ZRFI2658 PMid:40092121 PMCid:PMC11909539
27. Ahmad PMF, Ahmed SKA, Akhtar Y. Suranjan Shireen (Colchicum autumnale L.): A review on medicinal utility from the perspective of Unani Medicine. J Drug Delivery Ther. 2025;15(6):196-200. https://doi.org/10.22270/jddt.v15i6.7159
28. Leung YY, Yao Hui LL, Kraus VB. Colchicine—Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015 Dec;45(3):341-350. https://doi.org/10.1016/j.semarthrit.2015.06.013 PMid:26228647 PMCid:PMC4656054
29. MacColl E, Khalil RA. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease. J Pharmacol Exp Ther. 2015 Dec;355(3):410-428. https://doi.org/10.1124/jpet.115.227330 PMid:26319699 PMCid:PMC4658486
30. Suryono S, Rohman MS, Widjajanto E, Prayitnaningsih S, Wihastuti TA, Oktaviono YH. Effect of Colchicine in reducing MMP-9, NOX2, and TGF- β1 after myocardial infarction. BMC Cardiovasc Disord. 2023 Sep 11;23(1):449. https://doi.org/10.1186/s12872-023-03464-9 PMid:37697278 PMCid:PMC10496361
31. Handari SD, Rohman MS, Sargowo D, Aulanni’am A, Lestari B, Oceandy D. Colchicine modulates TIMP1, MMP1, and pMAP4 expression to enhance extracellular matrix degradation in 3T3 fibroblast-mediated myocardial infarction. J Pharm Pharmacogn Res. 2024;12(3):586-593. https://doi.org/10.56499/jppres23.1937_12.3.586
32. Akbari M, et al. Interrelationship between lipid profile, Vit-D, MMP-9, TIMP-1 and inflammatory cytokines in patients with coronary artery disease. J Cardiovasc Thorac Res. 2023;15(4):223-231. https://doi.org/10.34172/jcvtr.2023.31844 PMid:38357561 PMCid:PMC10862034
33. Zhou H, Khan D, Hussain SM, et al. Colchicine prevents oxidative stress-induced endothelial cell senescence via blocking NF-kappa B and MAPKs: implications in vascular diseases. Front Cardiovasc Med. 2023;10:1283624. https://doi.org/10.1101/2023.08.04.552075
34. Ali SZ, Nafees H, Ali MA. Detoxification and Processing of Crude Drugs in the Unani System of Medicine. In: Ali SZ, editor. Crude Drugs of Unani Medicine, Volume 1: Application and Utility for Human Welfare. 1st ed. Palm Bay: Apple Academic Press; 2024. p. 638. https://doi.org/10.1201/9781003637295-6
35. Singh D, Khan MA, Siddique HR, et al. Protective effects of a polyherbal medicine, Majoon Suranjan against bisphenol-A induced genetic, oxidative and tissue damages. Drug Chem Toxicol. 2022;45(5):2035-2046.
36. Alam S. Management of varicose vein (Dawālī) with Unani, contemporary, and phytomedicine: A historical and therapeutic review. J Res Unani Med. 2025;11(2):156-166. https://doi.org/10.4103/JRUM.JRUM_6_24
37. Azhar M, Mustehasan, Ayub S. Clinical evaluation of Taleeq in Dawali: A prospective study. Hippocratic J Unani Med. 2022;17(4):118-122. https://doi.org/10.4103/hjum.hjum_37_25
38. Mao Y, Zhou X. Global research trends and clinical trial progress in varicose vein treatment: A decade of advancements (2014-2024). Bibliometric analysis and clinical trial review. Medicine (Baltimore). 2025;104(12):e12885685. https://doi.org/10.1097/MD.0000000000047592 PMid:41650092 PMCid:PMC12885685
39. Larocque K, Ovadje P, Djurdjevic S, et al. Novel Analogue of Colchicine induces selective pro-death autophagy and necrosis in human cancer cells. PLoS One. 2014;9(1):e87084. https://doi.org/10.1371/journal.pone.0087064 PMid:24466327 PMCid:PMC3900699
40. Zhou H, et al. Meta-analysis of Randomized Controlled Trials on Colchicine in Secondary Prevention of Vascular Disease. Vascular Protection Journal. 2024;12(3).
41. Ansari AP, Ahmad NZ, Anwar N, et al. Majun-e-Suranjan and Habb-e-Azraqi are two Unani compound drugs that are effective and safe in cases of gout - An initial study. Indian J Tradit Knowl. 2023;22(4):708-716. https://doi.org/10.56042/ijtk.v22i4.7187
42. Rabe E, et al. Efficacy and Tolerability of a Red-vine-leaf Extract in Patients Suffering from Chronic Venous Insufficiency. Eur J Vasc Endovasc Surg. 2011;41(4):540-547. https://doi.org/10.1016/j.ejvs.2010.12.003 PMid:21239190
43. Raffetto JD. Matrix metalloproteinases and vein wall remodeling in varicose veins. J Vasc Surg. 2011;53(2):494-500.
44. Alivernini S, et al. Matrix Metalloproteinases-9 expression in the wall of varicose veins and local inflammation. J Vasc Surg. 2021;73(4).
45. Parveen T, Anees A, Bano SN, Noman N. Modern Insight into an ancient practice: Fasd (Venesection) for varicose vein Relief: A case study. J. Drug Delivery Ther. 2025;15(7):7-11 https://doi.org/10.22270/jddt.v15i7.7260
46. Ghazanfar K. Subchronic oral toxicity study of Habb-e-Suranjan in albino Wistar rats. J Complement Integr Med. 2018;15(3). https://doi.org/10.1515/jcim-2017-0144 PMid:29590082
47. Akbari M, et al. Serum levels and PBMC gene expression of MMP-9 and inflammatory markers in coronary artery disease. J Cardiovasc Thorac Res. 2023;15. PMCid:PMC10862034 https://doi.org/10.34172/jcvtr.2023.31844 PMid:38357561
48. Kucukguven A, Khalil RA. Matrix metalloproteinases in venous tissue remodeling and chronic venous disease. Adv Pharmacol. 2013;68:369-405.
49. J Clin Case Pract. Prospective evaluation of CEAP classification and VCSS in chronic venous disease. 2023;11.
50. Ahmad S, et al. Phytochemical Screening and Physicochemical Analysis of Colchicum luteum (Baker) corm. Res J Pharm Technol. 2023;16(12).
51. Alam MA, et al. Comprehensive explanation of black bile (Sauda) in Unani medicine. World J Pharm Med Res. 2024;10(1).
52. Yun S. Venoactive Drugs, Summary of the Clinical Trials and Guidelines. Ann Phlebology. 2021;19:21-26. https://doi.org/10.37923/phle.2021.19.2.21
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Mahboob us Salam, Vijay Bhan Singh , Faiyaz Ahmad , Bushra Sabir , Badruddeen, Minhajul Haque Ansari, Kaynat Fatima
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.